MedPath

Effects of tofogliflozin treatment on suppression of nocturia and promotion of urinary sodium excretion.

Not Applicable
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000048030
Lead Sponsor
Department of Metabolism and Endocrinology, Akita University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
36
Inclusion Criteria

Not provided

Exclusion Criteria

1) Type 2 diabetic patients who have an allergy against SGLT2 inhibitors 2) Type 2 diabetic patients who are pregnant

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath